Outcome | Strike group (women pregnant in 2017) n = 843 | Control group (women pregnant in 2018) n = 728 | Adjusted risk ratio [95% CI]; p-value d |
---|---|---|---|
4 or more ANC visits, n (%) | 463 (55%) | 507 (70%) | 0.83 [0.74,0.94]; 0.004 |
Delivered in a facility (public or private), n (%) | 452 (55%) | 514 (73%) | 0.84 [0.76,0.92]; < 0.001 |
Delivery location, n (%) | n/a | ||
Home alone | 75 (9%) | 43 (6%) | |
Home with TBA | 284 (34%) | 139 (20%) | |
In transit | 14 (2%) | 8 (1%) | |
Private facility | 316 (38%) | 77 (11%) | |
Public facility | 136 (17%) | 437 (62%) | |
Delivered at preferred location, n (%) | 268 (33%) | 514 (73%) | 0.49 [0.42,0.58]; < 0.001 |
Any delivery complications, n (%) a, b | 113 (19%) | 132 (25%) | 0.81 [0.59,1.11]; 0.185 |
Delivered a live child, n (%) | 794 (94%) | 696 (96%) | 1.00 [0.97, 1.02]; 0.711 |
Mean child birthweight, kgs (SD) | 3.40 (0.66) | 3.43 (0.76) | −0.04 [−0.13,0.06]; 0.442 c |
CHV visited home within 48 hours of birth, n (%) | 105 (13%) | 97 (14%) | 0.98 [0.68,1.43]; 0.92 |
Child received OPV 0 vaccine, n (%) b | 474 (83%) | 468 (89%) | 0.98 [0.93,1.03]; 0.356 |
Median days from birth to child receiving OPV 0 vaccine b | 13 | 7 | 8.02 [3.06,12.98]; 0.002 c |
Child alive at time of interview, n (%) | 772 (98%) | 675 (98%) | 1.00 [0.98,1.02]; 0.942 |